Favourite Existing Pharma Clusters in INDIA MIHAN- A well Preferred Destination Maharashtra Pharma Hub  Over 500 Units are operating in Mumbai, Amravati, Nagpur, Aurangabad, Nasik, Raigad, Ratnagiri, Thane in Maharashtra .  Over 120 Pharmaceutical Colleges in Maharashtra alone are making around 15000 Expert Graduates every year.  Excellent Weather Conditions & Social harmony Nagpur : Logistic Connectivity  Strategically Excellent Location for Long Term Perspective Advantage Nagpur

• Second Capital of the State • Strong backward linkages • Population of 3.1 million with • Strong urban & social 70% urban population infrastructure • Abundant water & power • Well-suited weather supply dynamics with Low Humidity • Low manpower costs • Less prone to earth-quake (Seismic Zone II)One of the • High quality Technical & greenest city of India Educational facilities • Only multi-product SEZ which is adjacent to an existing international airport Dry Port at Sindi in Wardha Area Approx. 142 Ha (350 acre) Investment @500 cr (65 Mn Euro) Facilities for EXIM based industries such as: Office of Central Drug Standard Control Org. Custom clearance Container freight station Warehousing Cold storage Liquid storage Truck terminal Dry Port at Sindi in Wardha Estimated traffic generation around 30000 TEUs by 2030 Bhumi Pujan on 2nd October 2017, phase I to be ready within one year. Dry Port is about 30 km from MIHAN Connected with Samruddhi Corridor, Central Railway, National Highway Nagpur–Mumbai

Samriddhi Expressway .

Length:700 Km

Est. Cost:46,000 Crore

A Highway to integrate Vidharbha and Marathwada with rest of Maharashtra Advantage MIHAN • Proximity to International Airport • Adjacent to National Highway • Connected with Nagpur Metro Rail • Functioning SEZ • Long term lease for 99 years in SEZ and 66 years in Non-SEZ area of MIHAN • Hassle free allotment process • Premier Institutes like IIM, AIIMS and Govt. Engg. College in MIHAN MIHAN - Overview Maharashtra Airport Development Co. Ltd (MADC) is a Nodal Agency & a Special Planning Authority for MIHAN Project Area – 4,061 Ha., Project Cost - $1.2 billion

Brief Area Allocation 1388.16 International Airport & Allied Activities/ Services Defence & Allied Activities / Services 400.00

Public / Semi Public Area 23.90

Special Economic Zone- Processing Area 1236.21

Mixed Use- Outside SEZ Processing Area 1013.20

Grand Total 4061.47 MIHAN- World Class Infrastructure

• 6 Lane Roads with Street Lights • Water Supply sourced from Dam at 15 km • Water Treatment Plant - Clean water supply • 100 MTPA Sewage Treatment Plant • 245 MW Thermal Power plant. Power supplied at Flat Rate of about Rs. 4.5/unit, • Free services of Dedicated Fire Station • Functional Storm Water Drainage • Telecommunication network with OFC Concessions /Subsidies of SEZ Duty free import / domestic procurement of Goods for development, operation and maintenance of SEZ units at MIHAN 100% Income Tax exemption – 1st 5 yrs

50% Next 5 years

50% of the ploughed back profit for the next 5 years External commercial borrowing up to US$500 million in a year without any maturity restriction through recognized banking channels. Domestic Procurement exempted from GST Concessions /Subsidies of SEZ

Power at a concessional rate.

Business Incubation at nominal Fee at CFB

Single window clearance for Central and State level approvals

Exemption from State tax and other levies as extended by the State Government

100% FDI allowed & Public Utility Service (PUS) status Present Status- Indian Pharma Mkt  Potential 55 Bn USD by 2020  Compounded Annual growth 15.92%  Expected to be top 3rd by incremental growth & 6th largest market globally in absolute size  3,000 Pharma companies with 10,500 mfg units  60 therapeutic categories. Over 60,000 generic brands  Largest exporter of Generic medicines globally  Indian vaccines are exported to 150 countries  Health Care to rise annually by 29% Present Status- Indian Pharma Mkt  Great Potential for Medical Tourism

 100% FDI allowed for Greenfield Pharma projects

 74% FDI for Brownfield Pharma projects

 Govt. allocation for Health- USD 8 billion

 New Health centres of USD 185 Million

 Govt. funded Healthcare Insurance- USD 7,700 /family

 Tax deduction of 200% for R&D for capital and revenue expenditure incurred on scientific research State FDA Initiatives

 E-Governance • Digitalization of Drugs Licensing system for manufacturing and sale of drugs since 2012

• Paperless online system for WHO-GMP Certification from 15th August, 2012. • Laboratory receipts, coding, issue of test reports online.

• Implemented Right to Services Act and notified timelines for the processing of the approvals application.

• Interface between Industry Development Department and Industries to facilitate new pharma investments. The quest of ideal location for happily ends at MIHAN Come & invest with us, we will be there with you for every support